| [1] |
Basso C. Myocarditis. N Engl J Med. 2022; 387(16):1488-1500.
|
| [2] |
Ammirati E, Veronese G, Bottiroli M, Wang DW, Cipriani M, Garascia A, et al. Update on acute myocarditis. Trends Cardiovasc Med. 2021; 31(6): 370-9.
|
| [3] |
Kociol RD, Cooper LT, Fang JC, Moslehi JJ, Pang PS, Sabe MA, et al. Recognition and initial management of fulminant myocarditis: a scientific statement from the American Heart Association. Circulation. 2020; 141(6): e69-e92.
|
| [4] |
Nunez JI, Grandin EW, Reyes-Castro T, Sabe M, Quintero P, Motiwala S, et al. Outcomes with peripheral venoarterial extracorporeal membrane oxygenation for suspected acute myocarditis: 10-year experience from the Extracorporeal Life Support Organization Registry. Circ Heart Fail. 2023; 16(7): e010152.
|
| [5] |
Lin R, Wang W, Wang X, Xu ZM, Liu JP, Zhou CB, et al. Perioperative extracorporeal membrane oxygenation in pediatric congenital heart disease: Chinese expert consensus. World J Pediatr. 2023; 19(1):7-19.
|
| [6] |
Alba AC, Foroutan F, Buchan TA, Alvarez J, Kinsella A, Clark K, et al. Mortality in patients with cardiogenic shock supported with VA ECMO: a systematic review and meta-analysis evaluating the impact of etiology on 29, 289 patients. J Heart Lung Transplant. 2021; 40(4): 260-8.
|
| [7] |
Gao SZ, Liu G, Yan SJ, Lou S, Gao GD, Hu Q, et al. Outcomes from adult veno-arterial extracorporeal membrane oxygenation in a cardiovascular disease center from 2009 to 2019. Perfusion. 2022; 37(3): 235-41.
|
| [8] |
Wang J, Wang J, Gao SZ, Liu G, Wang Q, Yan SJ, et al. Veno-arterial extracorporeal membrane oxygenation as a bridge in patients with advanced heart failure: initial experience in China. Chin Med J. 2024; 137(10): 1228-30.
|
| [9] |
Gaies MG, Gurney JG, Yen AH, Napoli ML, Gajarski RJ, Ohye RG, et al. Vasoactive-inotropic score as a predictor of morbidity and mortality in infants after cardiopulmonary bypass. Pediatr Crit Care Med. 2010; 11(2): 234-8.
|
| [10] |
Guglin M, Zucker MJ, Bazan VM, Bozkurt B, El Banayosy A, Estep JD, et al. Venoarterial ECMO for adults: JACC scientific expert panel. J Am Coll Cardiol. 2019; 73(6): 698-716.
doi: S0735-1097(18)39449-X
pmid: 30765037
|
| [11] |
Vishram-Nielsen JKK, Foroutan F, Rizwan S, Peck SS, Bodack J, Orchanian-Cheff A, et al. Patients with fulminant myocarditis supported with veno-arterial extracorporeal membrane oxygenation: a systematic review and meta-analysis of short-term mortality and impact of risk factors. Heart Fail Rev. 2023; 28(2): 347-57.
|
| [12] |
Kondo T, Okumura T, Shibata N, Imaizumi T, Dohi K, Izawa H, et al. Differences in prognosis and cardiac function according to required percutaneous mechanical circulatory support and histological findings in patients with fulminant myocarditis: insights from the CHANGE PUMP 2 study. J Am Heart Assoc. 2022; 11(4): e023719.
|
| [13] |
Chou HW, Wang CH, Lin LY, Chi NH, Chou NK, Yu HY, et al. Prognostic factors for heart recovery in adult patients with acute fulminant myocarditis and cardiogenic shock supported with extracorporeal membrane oxygenation. J Crit Care. 2020;57: 214-9.
|
| [14] |
Wheeler F, Lahr R, Espinosa J, Lucerna A, Schuitema H. Handheld bedside ultrasound in the diagnosis of myocarditis. World J Emerg Med, 2024, 15(1): 73-4.
doi: 10.5847/wjem.j.1920-8642.2024.010
pmid: 38188555
|
| [15] |
Płonka J, Gawda R, Sacha J, Bugajski J, Brzostowicz T, Molsa M, et al. Fulminant myocarditis and acute heart failure in the light of new American Heart Association 2020 guidelines. Mechanical cardiac support and endomyocardial biopsy. What should be first? Cardiol J. 2022; 29(4): 714-7.
|
| [16] |
Montero S, Aissaoui N, Tadié JM, Bizouarn P, Scherrer V, Persichini R, et al. Fulminant giant-cell myocarditis on mechanical circulatory support: management and outcomes of a French multicentre cohort. Int J Cardiol. 2018;253: 105-12.
|
| [17] |
Schultheiss HP, Escher F. Endomyocardial biopsy in fulminant myocarditis: need for early and accurate diagnosis to improve the outcome. Eur Heart J. 2023; 44(48): 5125-7.
|
)
